Literature DB >> 27403216

Primary Angioplasty Versus Stenting for Endovascular Management of Intracranial Atherosclerotic Disease Following Acute Ischemic Stroke.

Mark R Villwock, David J Padalino, Raghu Ramaswamy, Eric M Deshaies.   

Abstract

BACKGROUND: The future of neuroendovascular treatment for intracranial atherosclerotic disease (ICAD) has been debated since the results of SAMMPRIS reflected poor outcomes following endovascular therapy. There is currently a large spectrum of current management strategies. We compared historical outcomes of patients with ICAD and stroke that were treated with angioplasty-alone versus stent placement.
METHODS: We extracted a population from the Nationwide Inpatient Sample (NIS) (2005-2011) and the National Inpatient Sample (NIS) (2012) composed of patients with ICAD and infarction that were admitted nonelectively and received endovascular revascularization. Patients treated with thrombectomy or thrombolysis were excluded. Categorical variables were compared with Chi-squared tests. Binary logistic regression was performed to evaluate mortality while controlling for age, sex, severity, and comorbidities.
RESULTS: About 2059 admissions met our criteria. A majority were treated via stent placement (71%). Angioplasty-alone had significantly higher mortality (17.6% vs. 8.4%, P<0.001), but no difference in iatrogenic stroke rate (3.4% vs. 3.6%, P=0.826), compared to stent placement. The adjusted odds ratio of mortality for stented patients was 0.536 (95% CI: 0.381-0.753, P<0.001) in comparison to patients treated with angioplasty alone.
CONCLUSIONS: This study found the risk of mortality to be elevated following angioplasty alone in comparison to revascularization with stent placement, without a corresponding significant difference in iatrogenic stroke rate. This may represent selection bias due to patient characteristics not defined in the database, but it also may indicate that patients with ICAD and acute stroke have increased odds of stenosis that is refractory to angioplasty alone and have a high risk of mortality without revascularization.

Entities:  

Keywords:  Acute ischemic stroke; angioplasty; endovascular; intracranial stenosis; stent

Year:  2016        PMID: 27403216      PMCID: PMC4925754     

Source DB:  PubMed          Journal:  J Vasc Interv Neurol        ISSN: 1941-5893


  25 in total

Review 1.  Applications of stenting for intracranial atherosclerosis.

Authors:  Dale Ding; Kenneth C Liu
Journal:  Neurosurg Focus       Date:  2011-06       Impact factor: 4.047

2.  Reasons why data from the Nationwide Inpatient Sample can be misleading for carotid endarterectomy and carotid stenting.

Authors:  Norman R Hertzer
Journal:  Semin Vasc Surg       Date:  2012-03       Impact factor: 1.000

3.  National trends in utilization and postprocedure outcomes for carotid artery revascularization 2005 to 2007.

Authors:  Mohammad H Eslami; James T McPhee; Jessica P Simons; Andres Schanzer; Louis M Messina
Journal:  J Vasc Surg       Date:  2010-11-18       Impact factor: 4.268

4.  Intracranial stent placement for symptomatic intracranial stenosis as part of a clinical trial versus outside a clinical trial.

Authors:  Farhan Siddiq; Malik M Adil; Kiersten Norby; Adnan I Qureshi
Journal:  Stroke       Date:  2013-10-17       Impact factor: 7.914

5.  Intraventricular thrombolysis in intracerebral hemorrhage requiring ventriculostomy: a decade-long real-world experience.

Authors:  Yogesh Moradiya; Santosh B Murthy; David E Newman-Toker; Daniel F Hanley; Wendy C Ziai
Journal:  Stroke       Date:  2014-07-24       Impact factor: 7.914

6.  US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results.

Authors:  David Fiorella; Elad I Levy; Aquilla S Turk; Felipe C Albuquerque; David B Niemann; Beverly Aagaard-Kienitz; Ricardo A Hanel; Henry Woo; Peter A Rasmussen; L Nelson Hopkins; Thomas J Masaryk; Cameron G McDougall
Journal:  Stroke       Date:  2007-02-08       Impact factor: 7.914

7.  Use of the All Patient Refined-Diagnosis Related Group (APR-DRG) Risk of Mortality Score as a Severity Adjustor in the Medical ICU.

Authors:  Daniel Baram; Feroza Daroowalla; Ruel Garcia; Guangxiang Zhang; John J Chen; Erin Healy; Syed Ali Riaz; Paul Richman
Journal:  Clin Med Circ Respirat Pulm Med       Date:  2008-04-18

Review 8.  Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier.

Authors:  Philip B Gorelick; Ka Sing Wong; Hee-Joon Bae; Dilip K Pandey
Journal:  Stroke       Date:  2008-06-05       Impact factor: 7.914

9.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

10.  Impact of SAMMPRIS on the future of intracranial atherosclerotic disease management: polling results from the ICAD symposium at the International Stroke Conference.

Authors:  Osama O Zaidat; Alicia C Castonguay; Thanh N Nguyen; Kyra J Becker; Colin P Derdeyn; Peter K Nelson; Pierre Amarenco; Thomas G Brott
Journal:  J Neurointerv Surg       Date:  2013-04-06       Impact factor: 5.836

View more
  2 in total

Review 1.  Endovascular Therapy for Symptomatic Intracranial Artery Stenosis: a Systematic Review and Network Meta-analysis.

Authors:  Tao Wang; Kun Yang; Xiao Zhang; Jichang Luo; Ran Xu; Xue Wang; Yutong Yang; Xuesong Bai; Yan Ma; Yuxiang Yan; Liqun Jiao
Journal:  Transl Stroke Res       Date:  2022-02-12       Impact factor: 6.800

2.  Endovascular treatment for symptomatic intracranial artery stenosis: protocol for a systematic review and network meta-analysis.

Authors:  Tao Wang; Xue Wang; Kun Yang; Jing Zhang; Jichang Luo; Peng Gao; Yan Ma; Liqun Jiao; Feng Ling
Journal:  BMJ Open       Date:  2018-07-10       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.